SYF vs. REGN
SYF (Synchrony Financial) and REGN (Regeneron Pharmaceuticals, Inc.) are both stocks. SYF operates in Credit Services (Financial Services), while REGN operates in Biotechnology (Healthcare). Over the past 10 years, SYF returned 11.21%/yr vs 5.18%/yr for REGN. At a 0.20 correlation, their price movements are largely independent.
Performance
SYF vs. REGN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SYF achieves a -14.75% return, which is significantly higher than REGN's -20.58% return. Over the past 10 years, SYF has outperformed REGN with an annualized return of 11.21%, while REGN has yielded a comparatively lower 5.18% annualized return.
SYF
- 1D
- -0.41%
- 1M
- -3.54%
- YTD
- -14.75%
- 6M
- -10.85%
- 1Y
- 21.12%
- 3Y*
- 30.70%
- 5Y*
- 9.51%
- 10Y*
- 11.21%
REGN
- 1D
- -3.79%
- 1M
- -14.36%
- YTD
- -20.58%
- 6M
- -12.84%
- 1Y
- 24.63%
- 3Y*
- -6.19%
- 5Y*
- 3.39%
- 10Y*
- 5.18%
SYF vs. REGN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SYF Synchrony Financial | -14.75% | 30.64% | 74.01% | 19.76% | -27.43% | 36.40% | -0.08% | 57.48% | -37.84% | 8.35% |
REGN Regeneron Pharmaceuticals, Inc. | -20.58% | 8.96% | -18.90% | 21.73% | 14.25% | 30.72% | 28.66% | 0.53% | -0.65% | 2.42% |
Correlation
The correlation between SYF and REGN is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Aug 1, 2014 | 0.20 |
Fundamentals
SYF:
$24.41B
REGN:
$65.84B
SYF:
$9.85
REGN:
$41.05
SYF:
7.16
REGN:
14.89
SYF:
1.30
REGN:
4.42
SYF:
1.60
REGN:
2.10
SYF:
$19.92B
REGN:
$14.92B
SYF:
$12.16B
REGN:
$12.61B
SYF:
$4.94B
REGN:
$5.74B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SYF vs. REGN — Risk / Return Rank
SYF
REGN
SYF vs. REGN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Synchrony Financial (SYF) and Regeneron Pharmaceuticals, Inc. (REGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SYF | REGN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.02 | ||
| Sortino ratioReturn per unit of downside risk | -0.16 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.16 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 0.77 | 0.96 | -0.19 |
| Martin ratioReturn relative to average drawdown | 1.73 | 3.20 | -1.47 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SYF | REGN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.73 | 0.75 | -0.02 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.26 | 0.11 | +0.15 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.28 | 0.16 | +0.12 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 0.16 | +0.17 |
Drawdowns
SYF vs. REGN - Drawdown Comparison
The maximum SYF drawdown since its inception was -66.37%, smaller than the maximum REGN drawdown of -91.81%. Use the drawdown chart below to compare losses from any high point for SYF and REGN.
Loading charts...
Drawdown Indicators
| SYF | REGN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -66.37% | -91.81% | +25.44% |
Max Drawdown (1Y)Largest decline over 1 year | -27.61% | -25.85% | -1.76% |
Max Drawdown (3Y)Largest decline over 3 years | -37.75% | -59.69% | +21.94% |
Max Drawdown (5Y)Largest decline over 5 years | -46.65% | -59.69% | +13.04% |
Max Drawdown (10Y)Largest decline over 10 years | -66.37% | -59.69% | -6.68% |
Current DrawdownCurrent decline from peak | -19.61% | -48.71% | +29.10% |
Average DrawdownAverage peak-to-trough decline | -16.99% | -42.39% | +25.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.27% | 7.73% | +4.54% |
Volatility
SYF vs. REGN - Volatility Comparison
The current volatility for Synchrony Financial (SYF) is 8.21%, while Regeneron Pharmaceuticals, Inc. (REGN) has a volatility of 12.61%. This indicates that SYF experiences smaller price fluctuations and is considered to be less risky than REGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SYF | REGN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.21% | 12.61% | -4.40% |
Volatility (6M)Calculated over the trailing 6-month period | 23.13% | 22.61% | +0.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.15% | 33.09% | -3.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.74% | 30.82% | +5.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.52% | 32.18% | +7.34% |
Dividends
SYF vs. REGN - Dividend Comparison
SYF's dividend yield for the trailing twelve months is around 1.70%, more than REGN's 0.60% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals, Inc. | 0.60% | 0.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SYF Synchrony Financial | 1.70% | 1.38% | 1.54% | 2.51% | 2.74% | 1.90% | 2.54% | 2.39% | 3.07% | 1.45% | 0.72% |
Financials
SYF vs. REGN - Financials Comparison
This section allows you to compare key financial metrics between Synchrony Financial and Regeneron Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SYF vs. REGN - Profitability Comparison
SYF - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Synchrony Financial reported a gross profit of 4.64B and revenue of 5.60B. Therefore, the gross margin over that period was 82.7%.
REGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported a gross profit of 2.94B and revenue of 3.61B. Therefore, the gross margin over that period was 81.4%.
SYF - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Synchrony Financial reported an operating income of 914.00M and revenue of 5.60B, resulting in an operating margin of 16.3%.
REGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported an operating income of 642.90M and revenue of 3.61B, resulting in an operating margin of 17.8%.
SYF - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Synchrony Financial reported a net income of 805.00M and revenue of 5.60B, resulting in a net margin of 14.4%.
REGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported a net income of 727.20M and revenue of 3.61B, resulting in a net margin of 20.2%.
Frequently Asked Questions
SYF and REGN have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
REGN has higher volatility (12.61%) compared to SYF (8.21%). In terms of maximum drawdown, SYF dropped -66.37% vs REGN's -91.81%.
REGN currently has the higher Sharpe Ratio (0.75 vs 0.73), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SYF and REGN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer